The Global Drugs for Vulvovaginal Candidiasis Market is witnessing steady growth, driven by increasing prevalence of vaginal yeast infections and rising awareness regarding women’s health. According to market insights, the market is projected to expand at a consistent pace during the forecast period from 2025 to 2031, supported by advancements in antifungal drug formulations and improved...

NEWARK, DE — The global vaginal yeast infections treatment market is set for steady expansion, growing from USD 4.4 billion in 2026 to USD 7.7 billion by 2036, registering a CAGR of 5.7%, according to Future Market Insights (FMI). Market growth is primarily fueled by increasing prevalence of infections, rising patient awareness, and expanding access to over-the-counter (OTC) and...